Apconix at SfN 2026
Nov 14–18, 2026 Washington, DC ~21k attendees Website
Apconix brings 2 presentations to SfN 2026 in Washington. Its presentations centre on assessing unwanted effects on central nervous system ion channels and predicting sedation early in drug development. One thread combines human stem-cell-derived neurons with human ion-channel assays to predict sedation.
| Organization | SfN 2026 Attendance |
|---|---|
Apconix Macclesfield, UK | |
Contract research company providing toxicology and nonclinical safety assessment services for drug development. | Poster Sat Nov 14 1–5pm |
Instantly find 20 buyers from Apconix
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction